Please assess the completion status of the following clinical trial:

Trial Title: Routine Versus Selective Use of FFR to Guide PCI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects with stable coronary artery disease or recent acute coronary syndrome (ACS). Subjects who present with ST elevation myocardial infarction (STEMI) are allowed to be included after 5 days from initial presentation.~2. At least one obstructive coronary lesion is present with vessel reference diameter ≥2.5 mm and diameter stenosis ≥50% by visual estimate. Lesions must be technically suitable for the FFR procedure and angioplasty with stent placement.~3. Physician will classify all target lesions and need for FFR before randomization, and there is a plan to perform a non-emergent PCI.~4. Subject is ≥18 years old, with signed informed consent.~Exclusion Criteria:~1. Expected non-cardiac longevity \< 2 years.~2. Planned treatment with CABG.~3. Planned treatment with medical therapy.~4. Left main disease \> 50% diameter stenosis based on visual estimate.~5. Safety issues:~   1. Unstable hemodynamics or serious arrhythmias during procedure;~  2. Ongoing ischemic chest pain;~  3. High grade AV block (unless pacemaker);~  4. Allergic to adenosine.~6. When FFR is clearly not needed:~   1. Target vessel with slow flow (\< TIMI-3);~  2. Single vessel disease with ≥90% stenosis;~  3. Single vessel disease with ≥80% stenosis and documented ischemia on functional imaging test;~  4. In acute coronary syndrome, ≥70 stenosis identified as culprit.~7. When FFR is clearly needed for all target lesions: as declared by the operator.~8. Technical difficulty:~   1. Severe vessel tortuosity;~  2. Severe coronary calcification;~  3. Anticipate difficult wiring;~  4. Aorto-ostial lesion (ok for IV adenosine is used as the hyperemic agent).~9. Interpretation difficulty:~   1. Target vessel acting as a major collateral donor;~  2. When RA pressure very high;~  3. STEMI within past 5 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Routine use of FFR (Type: EXPERIMENTAL): Fractional Flow Reserve (FFR) used in most cases to guide PCI
- Selective use of FFR (Type: ACTIVE_COMPARATOR): Fractional Flow Reserve (FFR) used at investigator discretion (Current practice)

Based on this trial design, predict the completion outcome and termination type (if applicable).